Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;115(3):399-405.
doi: 10.1007/s12185-021-03260-1. Epub 2021 Nov 18.

Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt

Ilham Youssry  1 , Mona ElGhamrawy  1 , Hadeel Seif  2 , Lyn Balsamo  3 , Farzana Pashankar  3 , Mahmoud Mahrous  4 , Niveen Salama  5
Affiliations

Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt

Ilham Youssry et al. Int J Hematol. 2022 Mar.

Abstract

Little is known about cognitive impairment in patients with sickle cell disease in Africa. This study aimed to assess cognitive impairment and identify possible risk factors in patients with sickle cell disease in Egypt. This study was conducted at Cairo University Children Hospital. Patients with sickle cell disease, between ages of 6-20 years were enrolled. Cognitive ability was tested using the Stanford Binet intelligence quotient (IQ) test, fourth edition. Transcranial Doppler, magnetic resonance imaging and magnetic resonance angiography of the brain were performed within a week of the IQ test. Among the 40 enrolled patients, 55% had a Full Scale IQ at least 1 standard deviation below the mean, and 27.5% had an IQ 2 standard deviations below the mean. High lactate dehydrogenase was significantly associated with low IQ (p = 0.004). In univariate analyses, IQ was significantly correlated with older age (p = 0.025), high lactate dehydrogenase (p = 0.008) and older age at the start of hydroxyurea (p = 0.025). Impaired cognition is prevalent among sickle cell disease patients. Early initiation of hydroxyurea therapy, which should also reduce hemolysis and lactate dehydrogenase, may be a simple measure to preserve mental abilities in these patients.

Keywords: Cognition in SCD; Cognitive dysfunction; SCD in Egypt; TCD in SCD.

PubMed Disclaimer

References

    1. Steven A, Raghavan P, Rath TJ, Gandhi D. Neurologic and head and neck manifestations of sickle cell disease. Hematol Oncol Clin North Am. 2016;30(4):779–98. - DOI
    1. Lagunju IA, Brown BJ. Adverse neurological outcomes in Nigerian children with sickle cell disease. Int J Hematol. 2012;96(6):710–8. - DOI
    1. Fathallah H, Taher A, Bazarbachi A, Atweh GF. Differences in response to fetal hemoglobin induction therapy in β-thalassemia and sickle cell disease. Blood Cells Mol Dis. 2009;43(1):58–62. - DOI
    1. Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the cooperative study of sickle cell disease. J Pediatr. 2001;139(3):385–90. - DOI
    1. Adams RJ. TCD in sickle cell disease: an important and useful test. Pediatr Radiol. 2005;35(3):229–34. - DOI

MeSH terms

LinkOut - more resources